Government Operationalises Jan Vishwas Act Reforms in Health Sector; Rationalises Minor Offences under Drugs, Cosmetics and Food Safety Laws
I now have sufficient grounded facts from Tier 1 (PRS India, PIB) sources to write the study note. Let me compile it.
Study Note: Jan Vishwas Act Reforms in the Health Sector (2026)
Government Operationalises Reforms under Drugs, Cosmetics & Food Safety Laws
1. At a Glance
- Jan Vishwas (Amendment of Provisions) Bill, 2026 is a landmark decriminalisation statute that amends 80 Central Acts across 23 Ministries, replacing criminal penalties for minor/technical violations with graded civil/administrative penalties. [S1][S2]
- In the health sector, it directly amends the Drugs and Cosmetics Act, 1940, the Food Safety and Standards Act, 2006, the Pharmacy Act, 1948, the Clinical Establishments (Registration and Regulation) Act, 2010, and the National Commission for Allied and Healthcare Professions Act, 2021. [S2]
- Core policy rationale: Ease of Doing Business + trust-based governance — disproportionate criminal liability for technical lapses deters legitimate business; the reform inserts proportionality without weakening safeguards for serious public health offences. [S1]
- UPSC relevance: cuts across GS-II (governance, regulatory reform), GS-III (economy, pharma/food sectors), and essay/ethics themes of proportionate punishment and rule-based governance. [S3]
2. Why in the News
- March 27, 2026: Jan Vishwas (Amendment of Provisions) Bill, 2026 introduced in Lok Sabha. [S3]
- April 1, 2026: Passed by Lok Sabha; April 2, 2026: Passed by Rajya Sabha. [S3]
- June 26, 2026: Ministry of Health and Family Welfare (MoHFW) operationalises the health-sector provisions — issuing notifications bringing the reforms under the Drugs & Cosmetics Act and the Food Safety & Standards Act into effect. [S1]
- The PIB release of June 26, 2026 is the immediate current-affairs trigger.
3. Background & Evolution
- Jan Vishwas Act, 2023 (first generation): Amended 42 Central Acts, decriminalised 183 provisions across multiple ministries — the predecessor statute that established the template. [S2]
- The 2023 Act was widely seen as incomplete; a Select Committee was constituted that recommended expanding the scope significantly. [S3]
- Jan Vishwas (Amendment of Provisions) Bill, 2026 (second generation): Expands scope to 80 Acts / 784 provisions across 23 Ministries; the 2026 Bill replaced an earlier draft (2025 version) that covered only 17 Acts. [S3]
- Of 784 provisions amended: 717 provisions decriminalised (Ease of Doing Business); 67 provisions amended to facilitate Ease of Living. [S2]
- Root policy impulse: World Bank Ease of Doing Business rankings and India's aim to reduce regulatory overreach and pendency in criminal courts from technical violations of economic laws.
- Bharatiya Nyaya Sanhita, 2023 context: BNS replaced the IPC; Jan Vishwas 2026 explicitly removes duplicative offences from sector-specific laws already covered by the BNS (e.g., obstruction of Food Safety Officers now covered under BNS). [S2]
4. Core Static Facts
| Parameter | Detail |
|---|---|
| Full name | Jan Vishwas (Amendment of Provisions) Act, 2026 |
| Introduced | March 27, 2026 (Lok Sabha) |
| Passed — Lok Sabha | April 1, 2026 |
| Passed — Rajya Sabha | April 2, 2026 |
| Primary Ministry (nodal) | Ministry of Commerce and Industry |
| Health-sector Ministry | Ministry of Health and Family Welfare (MoHFW) |
| Total Acts amended | 80 Central Acts |
| Total provisions amended | 784 |
| Provisions decriminalised | 717 (Ease of Doing Business) |
| Provisions amended (Ease of Living) | 67 |
| Ministries covered | 23 |
| Health Acts covered | Drugs & Cosmetics Act 1940; Food Safety & Standards Act 2006; Pharmacy Act 1948; Clinical Establishments Act 2010; National Commission for Allied & Healthcare Professions Act 2021 |
| Penalty model | Civil/monetary penalty replacing imprisonment for minor violations |
| Cosmetics civil penalty | ₹1 lakh OR 3× value of cosmetics confiscated, whichever is higher |
| Penalty escalation | Automatic 10% upward revision every 3 years |
| Progressive enforcement | Advisory → Warning → Penalty (three-step ladder) |
| Adjudicating authority | Appointed by Central Govt / State Govts; can issue show-cause notices, conduct personal hearings; appellate mechanism provided |
| Sections specifically covered (Drugs Act) | Sections 27A(ii) and 28A (cosmetics — non-spurious, non-adulterated) |
| BNS alignment | Obstruction of Food Safety Officers removed from FSSA 2006 — subsumed under BNS |
[S1][S2][S3]
5. Multi-Dimensional Analysis
Economic
- Reduces compliance burden on pharma, cosmetics, and food processing MSMEs — minor procedural lapses (record-keeping, labelling deficiencies) no longer carry threat of imprisonment or protracted criminal litigation. [S2]
- India's pharma sector is the world's third-largest by volume; removal of disproportionate criminal liability signals to foreign investors a more predictable regulatory environment. [S1]
- Automatic 10% penalty escalation every 3 years ensures monetary deterrence remains meaningful and does not erode with inflation. [S3]
Legal / Constitutional
- Reflects the doctrine of proportionality in penal law: criminal sanctions must be commensurate with the severity of the offence — a principle recognised in multiple Supreme Court rulings. [S2]
- Introduction of a quasi-judicial adjudicating officer framework (show-cause notice + personal hearing + appeal) preserves natural justice requirements under Article 14. [S2]
- Removes duplication between sector-specific penal provisions and the Bharatiya Nyaya Sanhita, 2023, streamlining India's penal architecture. [S2]
- Serious offences — spurious drugs, adulterated cosmetics, unsafe food — remain under criminal law with full stringency; decriminalisation is strictly bounded to technical/minor violations. [S1]
Governance / Ethical
- Instantiates "trust-based governance" — regulatory philosophy that treats businesses as presumptively law-abiding; enforcement escalates only when good faith fails. [S1]
- Progressive enforcement ladder (advisory → warning → penalty) reduces inspector raj and arbitrary prosecution. [S2]
- Appellate mechanism guards against arbitrary adjudication — checks administrative power. [S2]
Administrative
- Creates new adjudicating authority infrastructure at both Central and State levels under the Drugs & Cosmetics Act — requires trained officers and clear jurisdictional demarcation. [S2]
- Risk of under-enforcement: replacing criminal courts with administrative panels may reduce deterrence if adjudicating authorities are under-resourced or captured by industry interests.
- Concurrent list dimension: Drugs & food safety are subjects where Centre sets standards but States enforce — reform must be absorbed by State regulatory machinery (FDA offices, food safety commissioners).
Social
- Consumer safety ring-fencing: only non-spurious, non-adulterated products with procedural lapses are decriminalised — critical protection maintained for end-consumers. [S1]
- Reduces risk of frivolous criminal complaints against small pharmacists, cosmetic manufacturers, and food vendors who lapse on paperwork but do not endanger health. [S2]
6. Recent Developments (last 12–18 months)
- March 27, 2026: Jan Vishwas (Amendment of Provisions) Bill, 2026 introduced in Lok Sabha. [S3]
- April 1, 2026: Passed by Lok Sabha. [S3]
- April 2, 2026: Passed by Rajya Sabha — becomes the Jan Vishwas Act, 2026. [S3]
- April 2026: PIB issues detailed background note on health-sector decriminalisation provisions, covering Drugs Act Section 27A(ii) and 28A adjudication mechanism. [S2]
- June 26, 2026: MoHFW operationalises health-sector provisions through gazette notifications — brings reforms under Drugs & Cosmetics Act 1940 and Food Safety & Standards Act 2006 into force. [S1]
7. Prelims Hooks (high-density factual bullets)
- Jan Vishwas (Amendment of Provisions) Act, 2026 amends 80 Central Acts administered by 23 Ministries. [S3]
- Of 784 total provisions amended, 717 provisions were decriminalised to promote Ease of Doing Business. [S2]
- The Bill was introduced in Lok Sabha on March 27, 2026; passed by Lok Sabha on April 1 and Rajya Sabha on April 2, 2026. [S3]
- The nodal Ministry for Jan Vishwas Act, 2026 is the Ministry of Commerce and Industry (not Health). [S3]
- Health-sector operationalisation was announced by Ministry of Health and Family Welfare on June 26, 2026. [S1]
- The civil penalty for cosmetics violations (minor) is ₹1 lakh OR 3× confiscated value, whichever is higher. [S3]
- Monetary penalties under the Act increase automatically by 10% every three years. [S3]
- Adjudication mechanism specifically introduced for Sections 27A(ii) and 28A of the Drugs and Cosmetics Act, 1940. [S2]
- Offences involving spurious or adulterated cosmetics/drugs are not decriminalised — strict criminal penal provisions continue. [S1][S2]
- The provision on obstruction of a Food Safety Officer was omitted from FSSA 2006 as it is already covered under the Bharatiya Nyaya Sanhita (BNS), 2023. [S2]
- Progressive enforcement ladder: Advisory → Warning → Penalty before prosecution for first/second violations. [S3]
- The predecessor statute is Jan Vishwas Act, 2023 which decriminalised 183 provisions across 42 Acts. [S2]
- The 2026 Bill replaced an earlier 2025 draft that covered only 17 Acts; a Select Committee expanded scope to 80 Acts. [S3]
- Clinical Establishments (Registration and Regulation) Act, 2010, and National Commission for Allied and Healthcare Professions Act, 2021, are among the five health Acts covered. [S2]
- The adjudicating authorities under the Drugs & Cosmetics Act are appointed by both Central and State Governments. [S2]
8. Mains Relevance
GS Paper Mapping:
| GS Paper | Syllabus Heading |
|---|---|
| GS-II | Government policies and interventions for development; Statutory/regulatory bodies |
| GS-II | Issues relating to design and implementation of government policies |
| GS-III | Indian Economy — regulatory reforms; Ease of Doing Business |
| GS-IV | Probity in governance; proportionality in punishment |
Plausible Mains Question Stems:
-
"The Jan Vishwas (Amendment of Provisions) Act, 2026 represents a paradigm shift from punitive to trust-based governance. Critically examine its implications for regulatory enforcement in India's health sector." (GS-II, 15 marks)
-
"Decriminalisation of minor offences under the Drugs and Cosmetics Act, 1940 and the Food Safety and Standards Act, 2006 is necessary for ease of doing business but risks weakening consumer protection. Analyse." (GS-III, 15 marks)
-
"Discuss the constitutional and governance dimensions of replacing criminal sanctions with administrative penalties in economic regulation in India." (GS-II + GS-IV, Essay)
9. Related Topics to Study Next
| Topic | Connection |
|---|---|
| Jan Vishwas Act, 2023 (first iteration) | Direct predecessor; understand scope vs. 2026 to avoid confusion in MCQs |
| Drugs and Cosmetics Act, 1940 | Parent statute being amended; know key definitions, schedules (H, X), and enforcement architecture |
| Food Safety and Standards Act, 2006 + FSSAI | Second major statute amended; understand FSSAI's role, standards-setting, food business operators |
| Bharatiya Nyaya Sanhita, 2023 | BNS integration is explicit in the reform — obstruction offences subsumed here |
| Ease of Doing Business (World Bank) | Policy context; India's rank trajectory, component indicators |
| Regulatory Impact Assessment (RIA) | Governance tool used to justify decriminalisation; growing part of Indian policy discourse |
| Clinical Establishments Act, 2010 | Also amended under this Act; links to healthcare regulation and accreditation |
| Competition Law & Antitrust | Analogous trend of replacing criminal penalties with civil/administrative fines in economic regulation |
10. Common Errors / Trap Areas
-
Wrong nodal Ministry: The Jan Vishwas Act, 2026 is administered by the Ministry of Commerce and Industry (Dept. for Promotion of Industry and Internal Trade — DPIIT), NOT by MoHFW. MoHFW operationalises the health-specific portions only. Confusing the two is a standard trap.
-
Conflating Jan Vishwas 2023 with Jan Vishwas 2026: The 2023 Act covered 42 Acts / 183 provisions; the 2026 Act covers 80 Acts / 784 provisions. Do not mix up these numbers — examiners exploit both sets.
-
Assuming all offences are decriminalised: Only minor/technical/procedural violations are decriminalised. Spurious drugs, adulterated cosmetics, and unsafe food offences continue to attract criminal prosecution. This public health safeguard is explicitly preserved.
-
Wrong year for Drugs & Cosmetics Act: The Act being amended is 1940 (not 1948 — that is the Pharmacy Act, which is also amended under Jan Vishwas 2026). These are two distinct statutes.
-
Misattributing BNS removal: The omission of the Food Safety Officer obstruction provision from FSSA 2006 is not a weakening of enforcement — it is a rationalisation because BNS 2023 already covers it. Framing it as reduced consumer protection is factually incorrect.
11. Sources
- [S1] Government Operationalises Jan Vishwas Act Reforms in Health Sector — Press Information Bureau (PIB), Ministry of Health and Family Welfare, June 26, 2026 — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2278118 — (Tier 1)
- [S2] Jan Vishwas (Amendment of Provisions) Bill, 2026: Rationalizing Compliance and Decriminalizing Minor Offences in the Health Sector — PIB, April 2026 — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2248831®=3&lang=1 — (Tier 1)
- [S3] The Jan Vishwas (Amendment of Provisions) Bill, 2026 — PRS Legislative Research — https://prsindia.org/billtrack/the-jan-vishwas-amendment-of-provisions-bill-2026 — (Tier 1)